All Pharma News
Indivior Announces Q1 2024 Financial Results

Indivior Announces Q1 2024 Financial Results
PR NEWSWIRE
25 Apr 2024
Share Share
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone

Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
PR NEWSWIRE
11 Mar 2024
Share Share
Court Provides Approval of Settlement with Purchaser in Antitrust Litigation

Court Provides Approval of Settlement with Purchaser in Antitrust Litigation
PR NEWSWIRE
29 Feb 2024
Share Share
Indivior Announces Q3 2023 Financial Results

Indivior Announces Q3 2023 Financial Results
PR NEWSWIRE
09 Nov 2023
Share Share
Indivior to fork over $385M in Suboxone antitrust settlement

Indivior to fork over $385M in Suboxone antitrust settlement
Zoey Becker FIERCE PHARMA
24 Oct 2023
Share Share
Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals

Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals
PR NEWSWIRE
11 Oct 2023
Share Share
Indivior Publishes Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses

Indivior Publishes Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses
PR NEWSWIRE
26 Sep 2023
Share Share
Click, Indivior to make digital therapeutics for addiction

Click, Indivior to make digital therapeutics for addiction
Andrea Park FIERCE BIOTECH
08 Sep 2023
Share Share
Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice

Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice
PR NEWSWIRE
28 Aug 2023
Share Share
Indivior Reaches Agreement with End Payor Class to Resolve Litigation Claims

Indivior Reaches Agreement with End Payor Class to Resolve Litigation Claims
PR NEWSWIRE
21 Aug 2023
Share Share